Pitfalls in measuring cerebrospinal fluid glycine levels in infants with encephalopathy

Samah Aburahma1, Mohammad Khassawneh, May Griebel

  • 1Jordan University of Science and Technology, Irbid, Jordan. samahk72@yahoo.com

Journal of Child Neurology
|February 22, 2011
PubMed

Insights

Elevated cerebrospinal fluid glycine levels in infants can occur in various conditions, not just nonketotic hyperglycinemia. This finding highlights the need for careful diagnosis in encephalopathic infants.

Area of Science:

  • Neurology
  • Biochemistry
  • Pediatrics

Background:

  • Cerebrospinal fluid (CSF) hyperglycinemia and elevated CSF to plasma glycine ratio are typically pathognomonic for nonketotic hyperglycinemia.
  • The diagnostic significance of these findings in acutely encephalopathic infants requires further evaluation.

Purpose of the Study:

  • To assess the significance of CSF hyperglycinemia and elevated CSF to plasma glycine ratio in acutely encephalopathic infants.
  • To determine the range of clinical conditions associated with elevated CSF glycine levels.

Main Methods:

  • Retrospective chart review of infants with isolated elevated CSF glycine levels.
  • Data collected from January 1995 to December 2000 at Arkansas Children's Hospital.
  • Analysis of 22 patient cases, including diagnoses and glycine ratio trends.

Main Results:

  • Hypoxic ischemic encephalopathy was the most common diagnosis (n=8).
  • Nine patients exhibited an elevated CSF to plasma glycine ratio.
  • The elevated ratio was transient in 7 of these 9 patients.

Conclusions:

  • Elevated CSF to plasma glycine ratio can be observed in diverse clinical scenarios beyond nonketotic hyperglycinemia.
  • The transient nature of this elevation suggests it may not always indicate a permanent metabolic disorder.
  • Further research is warranted to understand glycine's role in ischemic neuronal injury and its implications in infant encephalopathy.